TRANSMEMBRANE POLYPEPTIDE INVOLVED TO REGULATION OF ACTIVATION OF LYMPHOCYTES (VARIANTS), DNA (VARIANTS), VECTOR, STRAIN OF ESCHERICHIA COLI, POLYPEPTIDE FRAGMENT, HOMODIMERIC MOLECULE (VARIANTS), PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF DISEASE CAUSED BY ACTIVATION OF LYMPHOCYTES (VARIANTS), FUSED POLYPEPTIDE, MONOCLONAL ANTIBODY, HYBRIDOMA (VARIANTS) Russian patent published in 2003 - IPC

Abstract RU 2218350 C2

FIELD: biotechnology, molecular biology, medicine, pharmacy. SUBSTANCE: invention relates to molecule of cellular surface of mammal. Transmembrane polypeptide takes part in regulation of activation of lymphocytes and it is produced by transformants comprising the expression vector where DNA encoding polypeptide is inserted. Also, antibody is constructed that is able to bind with polypeptide specifically and it is produced by hybridoma. Polypeptide is a component of pharmaceutical composition that is used for treatment or prophylaxis of disease caused by activation of lymphocytes. EFFECT: valuable biological and medicinal properties of polypeptide and antibody. 29 cl, 39 dwg, 19 ex

Similar patents RU2218350C2

Title Year Author Number
NON-HUMAN ANIMALS HAVING HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3 2016
  • Mudzhika Aleksandr O.
  • Burova Elena
  • Merfi Endryu Dzh.
RU2745403C2
ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) 1998
  • Georgiev Georgij
  • Kiselev Sergej
  • Prokhorchuk Egor
  • Ostermann Ehlinborg
RU2238976C2
ISOLATED POLYPEPTIDE POSSESSING ANTIVIRAL ACTIVITY (VARIANTS), POLYNUCLEOTIDE ENCODING ITS (VARIANTS), EXPRESSING VECTOR, RECOMBINANT CELL-HOST, METHOD FOR PREPARING POLYPEPTIDE, ANTIBODY SPECIFIC TO POLYPEPTIDE AND POLYPEPTIDE-CONTAINING PHARMACEUTICAL COMPOSITION 2002
  • Sheppard Pol O.
  • Foks Brajan A.
  • Klacher Kevin M.
  • Tehft Dejvid U.
  • Kindsvogel Uehjn R.
RU2321594C2
POLYPEPTIDE WITH ANTIVIRAL, ANTIPROLIFERATIVE AND/OR IMMUNOMODULATING ACTIVITIES, SEPARATED POLYNUCLEOTIDE 2002
  • Ehskari Zhan-Lui
RU2328528C2
POLYPEPTIDES BINDING TO CD3 2013
  • Tan Filip Khuat
  • Nataradzhan Satish Kumar
  • Makmakhan Ketrin Dzh.
RU2673153C2
POLYNUCLEOTIDE SEQUENCE ENCODING PROTOCADGERINE PC3, PC4, PC5 (VARIANTS), PROTOCADGERINE POLYPEPTIDE PC3, PC4, PC5 (VARIANTS) 1995
  • Suzuki Sintaro
RU2197525C2
HUMANIZED MONOCLONAL ANTIBODY RAISED AGAINST AILIM, CO-STIMULATING MOLECULE FOR SIGNAL TRANSFER AND ITS PHARMACEUTICAL APPLYING 2001
  • Tsudzi Takasi
  • Tezuka Katsunari
  • Khori Nobuaki
RU2262511C2
MONOCLONAL ANTIBODIES AND METHODS OF USING THEM 2017
  • Britanova Olga Vladimirovna
  • Izraelson Mark Aleksandrovich
  • Lukyanov Sergej Anatolevich
RU2694412C2
IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS 2008
  • Karrer Ehrik E.
  • Pejdkhungat Madan M.
  • Bejs Stiven Kh.
  • Nejbors Margaret
  • Punnonen Jukha
  • Chepin Stiven Dzh.
  • Visvanatkhan Sridkhar
  • Larsen Brent R.
RU2506275C2
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) 1994
  • Lajmehn Stjuart D.
  • Bekmann M. Patritsija
RU2220979C2

RU 2 218 350 C2

Authors

Tamatani Takuja

Tezuka Katsunari

Dates

2003-12-10Published

1998-02-27Filed